Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine

Bromocriptine as Primary Therapy for Prolactin-Secreting Macroadenomas: Results of a Prospective Multicenter Study*

Mark E. Molitch, R. L. Elton, Richard E. Blackwell et al. · The Journal of Clinical Endocrinology & Metabolism · 1985 · 438 citations

Medicine, Endocrinology, Oncology +15

Rapid Changes of Prolactinoma Volume after Withdrawal and Reinstitution of Bromocriptine*

Michael O. Thorner, RICHARD L. PERRYMAN, Alan D. Rogol et al. · The Journal of Clinical Endocrinology & Metabolism · 1981 · 195 citations

Medicine, Endocrinology, Pharmacology +13

Size Reduction of Macroprolactinomas by Bromocriptine or Lisuride Treatment*

P. G. Chiodini, Antonio Liuzzi, Renato Cozzi et al. · The Journal of Clinical Endocrinology & Metabolism · 1981 · 143 citations

Pharmacy, Oncology, Pharmacotherapy +12

Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours

Sven Johan Nillius, Leif Wide · BMJ · 1978 · 132 citations · Full text

Medicine, Endocrinology, Surgery +14

Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas

P Konopka, J P Raymond, R E Merceron et al. · American Journal of Obstetrics and Gynecology · 1983 · 113 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +14